Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myocardial Ischemia | 23 | 2017 | 2139 | 1.660 |
Why?
|
Hypercholesterolemia | 9 | 2012 | 1145 | 1.420 |
Why?
|
Stilbenes | 8 | 2013 | 155 | 1.190 |
Why?
|
Surgical Wound Dehiscence | 4 | 2023 | 216 | 1.010 |
Why?
|
Naproxen | 3 | 2011 | 101 | 0.830 |
Why?
|
Myocardium | 16 | 2020 | 4790 | 0.720 |
Why?
|
Coronary Circulation | 10 | 2012 | 1617 | 0.720 |
Why?
|
Sternotomy | 6 | 2023 | 132 | 0.670 |
Why?
|
Alcoholic Beverages | 5 | 2012 | 266 | 0.650 |
Why?
|
Wine | 5 | 2017 | 172 | 0.630 |
Why?
|
Swine | 31 | 2017 | 5998 | 0.620 |
Why?
|
Sternum | 4 | 2023 | 177 | 0.620 |
Why?
|
Collateral Circulation | 7 | 2012 | 291 | 0.620 |
Why?
|
Neovascularization, Physiologic | 10 | 2014 | 1371 | 0.620 |
Why?
|
Carbon Monoxide | 1 | 2021 | 552 | 0.600 |
Why?
|
Surgical Wound Infection | 4 | 2023 | 1546 | 0.570 |
Why?
|
Cardiopulmonary Bypass | 7 | 2022 | 1097 | 0.540 |
Why?
|
Oxidative Stress | 10 | 2020 | 3138 | 0.530 |
Why?
|
Cyclooxygenase Inhibitors | 3 | 2011 | 361 | 0.490 |
Why?
|
Sulfonamides | 4 | 2011 | 1982 | 0.440 |
Why?
|
Myocardial Reperfusion Injury | 3 | 2011 | 484 | 0.420 |
Why?
|
Pyrazoles | 3 | 2011 | 2029 | 0.410 |
Why?
|
Cyclooxygenase 2 Inhibitors | 2 | 2011 | 321 | 0.400 |
Why?
|
Swine, Miniature | 16 | 2014 | 965 | 0.400 |
Why?
|
Prostaglandins | 2 | 2011 | 398 | 0.370 |
Why?
|
Vascular Endothelial Growth Factor A | 5 | 2013 | 3518 | 0.350 |
Why?
|
Apoptosis | 10 | 2020 | 9528 | 0.350 |
Why?
|
Ethanol | 5 | 2017 | 1332 | 0.350 |
Why?
|
Warm Ischemia | 1 | 2010 | 59 | 0.340 |
Why?
|
Heart | 4 | 2012 | 4448 | 0.320 |
Why?
|
Tricuspid Valve | 2 | 2024 | 419 | 0.310 |
Why?
|
Coronary Vessels | 7 | 2012 | 3124 | 0.300 |
Why?
|
Echocardiography, Three-Dimensional | 2 | 2024 | 615 | 0.300 |
Why?
|
Thrombin | 1 | 2010 | 600 | 0.290 |
Why?
|
Coronary Artery Disease | 8 | 2022 | 6569 | 0.290 |
Why?
|
Endothelium | 1 | 2010 | 768 | 0.290 |
Why?
|
Heptanoic Acids | 3 | 2014 | 344 | 0.290 |
Why?
|
Heart Arrest, Induced | 3 | 2013 | 361 | 0.270 |
Why?
|
Organ Preservation | 1 | 2010 | 394 | 0.260 |
Why?
|
Myocardial Revascularization | 3 | 2019 | 796 | 0.260 |
Why?
|
Angiogenesis Inducing Agents | 3 | 2012 | 254 | 0.260 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2022 | 4064 | 0.260 |
Why?
|
Arterioles | 5 | 2013 | 252 | 0.260 |
Why?
|
Heart Valve Prosthesis Implantation | 3 | 2023 | 1568 | 0.250 |
Why?
|
Disease Models, Animal | 21 | 2017 | 18366 | 0.230 |
Why?
|
Blood Proteins | 1 | 2010 | 1191 | 0.230 |
Why?
|
Coronary Artery Bypass | 4 | 2022 | 2194 | 0.230 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2010 | 1124 | 0.220 |
Why?
|
Immunoblotting | 5 | 2020 | 1647 | 0.220 |
Why?
|
Diabetes Complications | 1 | 2010 | 1320 | 0.220 |
Why?
|
Dietary Fats | 1 | 2011 | 2003 | 0.220 |
Why?
|
Pyrroles | 3 | 2014 | 1126 | 0.220 |
Why?
|
Cell Survival | 2 | 2010 | 5794 | 0.210 |
Why?
|
Aortic Valve Stenosis | 3 | 2023 | 2034 | 0.210 |
Why?
|
Energy Metabolism | 3 | 2012 | 2905 | 0.210 |
Why?
|
Debridement | 2 | 2022 | 494 | 0.200 |
Why?
|
Heart Valve Diseases | 2 | 2021 | 1030 | 0.200 |
Why?
|
Mitral Valve Insufficiency | 2 | 2022 | 1415 | 0.200 |
Why?
|
Hemodynamics | 5 | 2012 | 4199 | 0.190 |
Why?
|
Thromboxane A2 | 2 | 2011 | 87 | 0.190 |
Why?
|
Muscle, Skeletal | 6 | 2017 | 4980 | 0.190 |
Why?
|
Animals | 38 | 2021 | 169408 | 0.180 |
Why?
|
Cardiotonic Agents | 2 | 2014 | 544 | 0.180 |
Why?
|
Neuropeptide Y | 2 | 2012 | 194 | 0.180 |
Why?
|
RNA | 3 | 2020 | 2727 | 0.180 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2024 | 362 | 0.170 |
Why?
|
Thrombolytic Therapy | 2 | 2020 | 2053 | 0.170 |
Why?
|
Microcirculation | 4 | 2012 | 1281 | 0.170 |
Why?
|
Up-Regulation | 3 | 2020 | 4148 | 0.160 |
Why?
|
Peptide Fragments | 2 | 2020 | 5150 | 0.160 |
Why?
|
Embolectomy | 1 | 2020 | 130 | 0.160 |
Why?
|
Random Allocation | 3 | 2017 | 2396 | 0.160 |
Why?
|
Cardiac Surgical Procedures | 3 | 2022 | 3683 | 0.160 |
Why?
|
Receptors, Notch | 2 | 2014 | 751 | 0.160 |
Why?
|
Perfusion | 4 | 2011 | 1402 | 0.160 |
Why?
|
Cyclooxygenase 2 | 2 | 2011 | 599 | 0.150 |
Why?
|
Vena Cava Filters | 2 | 2020 | 270 | 0.150 |
Why?
|
Myocardial Infarction | 4 | 2019 | 11521 | 0.150 |
Why?
|
Signal Transduction | 11 | 2014 | 23652 | 0.140 |
Why?
|
Ultrasonography, Doppler | 1 | 2019 | 463 | 0.140 |
Why?
|
Patient Care Team | 2 | 2020 | 2527 | 0.140 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2021 | 417 | 0.140 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2020 | 1483 | 0.140 |
Why?
|
Heart Diseases | 3 | 2018 | 2819 | 0.140 |
Why?
|
Metformin | 3 | 2014 | 909 | 0.140 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2019 | 262 | 0.140 |
Why?
|
Intraoperative Care | 1 | 2021 | 771 | 0.140 |
Why?
|
Endothelial Cells | 1 | 2010 | 3591 | 0.140 |
Why?
|
Ventricular Function, Left | 5 | 2012 | 3941 | 0.130 |
Why?
|
Muscle Contraction | 2 | 2011 | 1209 | 0.130 |
Why?
|
Blood Transfusion | 1 | 2022 | 1309 | 0.130 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2010 | 3447 | 0.130 |
Why?
|
Thoracic Surgery | 1 | 2022 | 729 | 0.120 |
Why?
|
Hospital Mortality | 2 | 2020 | 5369 | 0.120 |
Why?
|
Enzyme Induction | 2 | 2012 | 455 | 0.120 |
Why?
|
Pulmonary Embolism | 2 | 2020 | 2598 | 0.120 |
Why?
|
Insulin | 5 | 2012 | 6610 | 0.120 |
Why?
|
Thromboxanes | 2 | 2011 | 45 | 0.120 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2014 | 3253 | 0.120 |
Why?
|
Nitric Oxide Synthase Type III | 3 | 2012 | 706 | 0.120 |
Why?
|
Diabetes Mellitus | 3 | 2020 | 5892 | 0.120 |
Why?
|
Blotting, Western | 5 | 2017 | 5035 | 0.120 |
Why?
|
Male | 41 | 2024 | 365249 | 0.120 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2012 | 2063 | 0.110 |
Why?
|
Lipid Peroxidation | 2 | 2012 | 276 | 0.110 |
Why?
|
Reference Values | 2 | 2011 | 4941 | 0.110 |
Why?
|
Immunohistochemistry | 6 | 2017 | 11119 | 0.110 |
Why?
|
Sus scrofa | 2 | 2012 | 430 | 0.110 |
Why?
|
Heart Function Tests | 2 | 2011 | 317 | 0.110 |
Why?
|
Epoprostenol | 2 | 2011 | 246 | 0.110 |
Why?
|
Endothelium, Vascular | 4 | 2012 | 4428 | 0.110 |
Why?
|
Administration, Oral | 2 | 2011 | 4042 | 0.110 |
Why?
|
Amyloidosis | 1 | 2021 | 879 | 0.110 |
Why?
|
Hypoglycemic Agents | 4 | 2014 | 3110 | 0.110 |
Why?
|
Chemokines | 1 | 2017 | 963 | 0.100 |
Why?
|
Diet, Atherogenic | 1 | 2012 | 92 | 0.100 |
Why?
|
Oxygen | 2 | 2022 | 4273 | 0.100 |
Why?
|
Thrombectomy | 1 | 2017 | 675 | 0.100 |
Why?
|
Caspase 3 | 2 | 2014 | 731 | 0.100 |
Why?
|
Alcohols | 1 | 2012 | 94 | 0.100 |
Why?
|
Interleukins | 1 | 2017 | 796 | 0.100 |
Why?
|
Vasoconstriction | 2 | 2012 | 593 | 0.100 |
Why?
|
Sarcopenia | 1 | 2017 | 377 | 0.100 |
Why?
|
Chymases | 1 | 2011 | 84 | 0.100 |
Why?
|
Humans | 39 | 2024 | 768887 | 0.090 |
Why?
|
Vasodilation | 2 | 2012 | 967 | 0.090 |
Why?
|
Treatment Outcome | 11 | 2023 | 65485 | 0.090 |
Why?
|
Muscle, Smooth, Vascular | 3 | 2013 | 1493 | 0.090 |
Why?
|
Fractures, Bone | 1 | 2023 | 2063 | 0.090 |
Why?
|
Gene Expression Regulation | 5 | 2018 | 11934 | 0.090 |
Why?
|
Autophagy | 2 | 2020 | 1351 | 0.090 |
Why?
|
Vasoconstrictor Agents | 2 | 2011 | 657 | 0.090 |
Why?
|
Pericardium | 2 | 2012 | 679 | 0.090 |
Why?
|
Myocardial Reperfusion | 1 | 2011 | 339 | 0.090 |
Why?
|
Raffinose | 1 | 2010 | 57 | 0.090 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2011 | 174 | 0.090 |
Why?
|
Procaine | 1 | 2010 | 60 | 0.090 |
Why?
|
Female | 24 | 2024 | 397464 | 0.080 |
Why?
|
Potassium Chloride | 1 | 2010 | 229 | 0.080 |
Why?
|
Atrial Appendage | 1 | 2013 | 285 | 0.080 |
Why?
|
Blood Chemical Analysis | 1 | 2011 | 436 | 0.080 |
Why?
|
Mannitol | 1 | 2010 | 177 | 0.080 |
Why?
|
Organ Preservation Solutions | 1 | 2010 | 104 | 0.080 |
Why?
|
Coronary Angiography | 5 | 2012 | 4541 | 0.080 |
Why?
|
Phytotherapy | 1 | 2011 | 298 | 0.080 |
Why?
|
Endothelin-1 | 1 | 2010 | 296 | 0.080 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2017 | 3814 | 0.080 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2010 | 414 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 478 | 0.080 |
Why?
|
Sensitivity and Specificity | 3 | 2017 | 14751 | 0.080 |
Why?
|
Mitral Valve | 3 | 2022 | 1475 | 0.080 |
Why?
|
Allopurinol | 1 | 2010 | 202 | 0.080 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2012 | 881 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2012 | 2460 | 0.080 |
Why?
|
Angiogenic Proteins | 3 | 2014 | 101 | 0.070 |
Why?
|
Hemorrhage | 1 | 2020 | 3465 | 0.070 |
Why?
|
Aged | 19 | 2024 | 171790 | 0.070 |
Why?
|
Cholesterol, Dietary | 3 | 2014 | 224 | 0.070 |
Why?
|
Sodium Chloride | 1 | 2010 | 584 | 0.070 |
Why?
|
Plant Extracts | 1 | 2011 | 499 | 0.070 |
Why?
|
Echocardiography, Transesophageal | 2 | 2024 | 1096 | 0.070 |
Why?
|
Glutathione | 1 | 2010 | 589 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2020 | 3626 | 0.070 |
Why?
|
Risk Factors | 6 | 2023 | 74971 | 0.070 |
Why?
|
Models, Cardiovascular | 1 | 2012 | 983 | 0.070 |
Why?
|
Phosphorylation | 3 | 2012 | 8317 | 0.070 |
Why?
|
Erythrocyte Transfusion | 2 | 2022 | 575 | 0.070 |
Why?
|
Myocardial Contraction | 1 | 2011 | 1526 | 0.060 |
Why?
|
Liver | 2 | 2012 | 7579 | 0.060 |
Why?
|
Staining and Labeling | 1 | 2010 | 1081 | 0.060 |
Why?
|
Databases, Factual | 1 | 2021 | 8095 | 0.060 |
Why?
|
Renin-Angiotensin System | 1 | 2010 | 736 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2012 | 6242 | 0.060 |
Why?
|
Retrospective Studies | 7 | 2023 | 81892 | 0.060 |
Why?
|
Adenosine | 1 | 2010 | 822 | 0.060 |
Why?
|
Cryopreservation | 1 | 2010 | 733 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2011 | 2277 | 0.060 |
Why?
|
Antioxidants | 1 | 2012 | 1673 | 0.060 |
Why?
|
Cardiovascular System | 1 | 2011 | 840 | 0.060 |
Why?
|
Neovascularization, Pathologic | 2 | 2014 | 2634 | 0.060 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2014 | 3613 | 0.050 |
Why?
|
Heart Arrest | 1 | 2013 | 1515 | 0.050 |
Why?
|
Vasodilator Agents | 3 | 2012 | 990 | 0.050 |
Why?
|
Microvessels | 3 | 2012 | 586 | 0.050 |
Why?
|
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 2 | 2012 | 64 | 0.050 |
Why?
|
Blood Glucose | 3 | 2012 | 6434 | 0.050 |
Why?
|
Anticoagulants | 1 | 2017 | 4850 | 0.050 |
Why?
|
Pectoralis Muscles | 1 | 2022 | 86 | 0.050 |
Why?
|
Glucose Transporter Type 4 | 2 | 2012 | 241 | 0.050 |
Why?
|
Middle Aged | 10 | 2024 | 223740 | 0.050 |
Why?
|
Insulin Resistance | 2 | 2012 | 3982 | 0.050 |
Why?
|
Length of Stay | 3 | 2021 | 6525 | 0.050 |
Why?
|
Aortic Valve | 2 | 2023 | 1969 | 0.050 |
Why?
|
Protein Kinase C-alpha | 2 | 2012 | 113 | 0.050 |
Why?
|
Drug Therapy, Combination | 1 | 2011 | 6320 | 0.050 |
Why?
|
Tissue Adhesions | 2 | 2012 | 223 | 0.050 |
Why?
|
Gene Expression Profiling | 2 | 2014 | 9549 | 0.050 |
Why?
|
Lipids | 1 | 2011 | 3345 | 0.040 |
Why?
|
Insulin Receptor Substrate Proteins | 2 | 2012 | 558 | 0.040 |
Why?
|
Cognition Disorders | 1 | 2014 | 3985 | 0.040 |
Why?
|
Fibrosis | 3 | 2012 | 2081 | 0.040 |
Why?
|
Papillary Muscles | 1 | 2021 | 192 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2892 | 0.040 |
Why?
|
Liver Function Tests | 2 | 2012 | 526 | 0.040 |
Why?
|
Plaque, Atherosclerotic | 1 | 2011 | 1550 | 0.040 |
Why?
|
Medicare | 1 | 2018 | 6888 | 0.040 |
Why?
|
Alcohol Drinking | 1 | 2012 | 4045 | 0.040 |
Why?
|
Time | 1 | 2021 | 552 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2013 | 12252 | 0.040 |
Why?
|
Cause of Death | 2 | 2020 | 3721 | 0.040 |
Why?
|
Suture Techniques | 1 | 2023 | 779 | 0.040 |
Why?
|
Independent Living | 1 | 2023 | 584 | 0.040 |
Why?
|
Heart Failure | 1 | 2022 | 11879 | 0.040 |
Why?
|
Glucose | 1 | 2010 | 4352 | 0.040 |
Why?
|
Thrombosis | 1 | 2011 | 2956 | 0.040 |
Why?
|
Chronic Disease | 4 | 2014 | 9384 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2020 | 20776 | 0.040 |
Why?
|
Inflammation | 3 | 2012 | 10869 | 0.040 |
Why?
|
Coronary Disease | 1 | 2011 | 5919 | 0.030 |
Why?
|
Cardiovascular Diseases | 2 | 2013 | 15662 | 0.030 |
Why?
|
Macrophages | 1 | 2011 | 5800 | 0.030 |
Why?
|
Comorbidity | 1 | 2011 | 10591 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2013 | 1658 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2012 | 10778 | 0.030 |
Why?
|
Myocardial Perfusion Imaging | 2 | 2012 | 672 | 0.030 |
Why?
|
Sex Factors | 2 | 2021 | 10641 | 0.030 |
Why?
|
Survival Rate | 2 | 2021 | 12873 | 0.030 |
Why?
|
Ventricular Remodeling | 1 | 2022 | 1282 | 0.030 |
Why?
|
Heat-Shock Proteins | 1 | 2018 | 797 | 0.030 |
Why?
|
Intracranial Hemorrhages | 1 | 2020 | 811 | 0.030 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2020 | 644 | 0.030 |
Why?
|
Prospective Studies | 3 | 2024 | 54950 | 0.030 |
Why?
|
Thorax | 1 | 2017 | 557 | 0.030 |
Why?
|
Heart Ventricles | 2 | 2020 | 3840 | 0.030 |
Why?
|
Ischemia | 1 | 2022 | 1900 | 0.030 |
Why?
|
bcl-2-Associated X Protein | 1 | 2014 | 282 | 0.030 |
Why?
|
Cardioplegic Solutions | 1 | 2013 | 123 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2021 | 1422 | 0.030 |
Why?
|
Radioimmunoprecipitation Assay | 1 | 2012 | 16 | 0.030 |
Why?
|
Protein Kinase C-epsilon | 1 | 2012 | 43 | 0.030 |
Why?
|
Receptors, Neuropeptide Y | 1 | 2012 | 47 | 0.030 |
Why?
|
Focal Adhesion Kinase 2 | 1 | 2012 | 87 | 0.030 |
Why?
|
Inflammation Mediators | 2 | 2012 | 1890 | 0.030 |
Why?
|
Thoracic Vertebrae | 1 | 2017 | 614 | 0.030 |
Why?
|
Nitroprusside | 1 | 2012 | 272 | 0.030 |
Why?
|
Glucose Transporter Type 1 | 1 | 2012 | 186 | 0.020 |
Why?
|
Retinol-Binding Proteins, Plasma | 1 | 2012 | 94 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2017 | 1627 | 0.020 |
Why?
|
Receptors, Thromboxane A2, Prostaglandin H2 | 1 | 2011 | 10 | 0.020 |
Why?
|
Thromboxane-A Synthase | 1 | 2011 | 34 | 0.020 |
Why?
|
Aorta | 1 | 2019 | 2046 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2012 | 126 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15955 | 0.020 |
Why?
|
Reoperation | 2 | 2012 | 4342 | 0.020 |
Why?
|
Adenosine Diphosphate | 1 | 2012 | 422 | 0.020 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2020 | 1751 | 0.020 |
Why?
|
Substance P | 1 | 2012 | 332 | 0.020 |
Why?
|
PPAR alpha | 1 | 2012 | 177 | 0.020 |
Why?
|
Organ Culture Techniques | 1 | 2013 | 796 | 0.020 |
Why?
|
Type C Phospholipases | 1 | 2011 | 287 | 0.020 |
Why?
|
Receptors, Endothelin | 1 | 2010 | 56 | 0.020 |
Why?
|
Angiostatins | 1 | 2010 | 64 | 0.020 |
Why?
|
Venous Thrombosis | 1 | 2020 | 1321 | 0.020 |
Why?
|
Capillaries | 1 | 2013 | 756 | 0.020 |
Why?
|
Muscle Cells | 1 | 2011 | 195 | 0.020 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2012 | 481 | 0.020 |
Why?
|
Coronary Artery Bypass, Off-Pump | 1 | 2010 | 65 | 0.020 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2011 | 394 | 0.020 |
Why?
|
Caspases | 1 | 2012 | 881 | 0.020 |
Why?
|
Gene Expression | 2 | 2012 | 7602 | 0.020 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2012 | 598 | 0.020 |
Why?
|
Leptin | 1 | 2017 | 1597 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2013 | 1083 | 0.020 |
Why?
|
Species Specificity | 1 | 2013 | 2419 | 0.020 |
Why?
|
Blood Gas Analysis | 1 | 2010 | 384 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2014 | 1151 | 0.020 |
Why?
|
Hematocrit | 1 | 2010 | 623 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2011 | 755 | 0.020 |
Why?
|
Sphingosine | 1 | 2010 | 308 | 0.020 |
Why?
|
Peptides, Cyclic | 1 | 2010 | 391 | 0.020 |
Why?
|
Tyrosine | 1 | 2012 | 1427 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 2475 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2011 | 1183 | 0.020 |
Why?
|
Protein Kinase C | 1 | 2012 | 1207 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2014 | 1494 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39394 | 0.020 |
Why?
|
Lumbar Vertebrae | 1 | 2017 | 1889 | 0.020 |
Why?
|
Echocardiography | 1 | 2020 | 5046 | 0.020 |
Why?
|
Mortality | 1 | 2019 | 2915 | 0.020 |
Why?
|
Ventricular Fibrillation | 1 | 2010 | 537 | 0.020 |
Why?
|
Thiophenes | 1 | 2011 | 570 | 0.020 |
Why?
|
Forkhead Transcription Factors | 1 | 2014 | 1625 | 0.020 |
Why?
|
Body Temperature | 1 | 2010 | 781 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2021 | 12469 | 0.020 |
Why?
|
Time Factors | 3 | 2014 | 40266 | 0.020 |
Why?
|
Dietary Carbohydrates | 1 | 2011 | 896 | 0.020 |
Why?
|
Patient Readmission | 1 | 2020 | 3313 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2012 | 1794 | 0.020 |
Why?
|
Cadherins | 1 | 2010 | 906 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2011 | 3588 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2011 | 1973 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13317 | 0.020 |
Why?
|
Protein Transport | 1 | 2011 | 1956 | 0.020 |
Why?
|
Mitochondria | 1 | 2018 | 3683 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2011 | 2226 | 0.020 |
Why?
|
Oligopeptides | 1 | 2010 | 1194 | 0.010 |
Why?
|
Arteries | 1 | 2010 | 1126 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2012 | 1966 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14795 | 0.010 |
Why?
|
Massachusetts | 1 | 2017 | 8888 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4593 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2011 | 2635 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2012 | 22294 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2019 | 4338 | 0.010 |
Why?
|
Collagen | 1 | 2012 | 2646 | 0.010 |
Why?
|
Energy Intake | 1 | 2011 | 2146 | 0.010 |
Why?
|
Robotics | 1 | 2010 | 826 | 0.010 |
Why?
|
Nitric Oxide | 1 | 2012 | 2149 | 0.010 |
Why?
|
Regeneration | 1 | 2012 | 1524 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2019 | 59738 | 0.010 |
Why?
|
Risk Assessment | 1 | 2023 | 24330 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3811 | 0.010 |
Why?
|
Cholesterol | 1 | 2011 | 2913 | 0.010 |
Why?
|
Piperidines | 1 | 2010 | 1669 | 0.010 |
Why?
|
Prevalence | 1 | 2018 | 15875 | 0.010 |
Why?
|
Tachycardia, Ventricular | 1 | 2010 | 1309 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2010 | 2026 | 0.010 |
Why?
|
Fibroblasts | 1 | 2011 | 4178 | 0.010 |
Why?
|
Prognosis | 1 | 2021 | 30044 | 0.010 |
Why?
|
United States | 2 | 2019 | 73180 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2011 | 8200 | 0.010 |
Why?
|
Angiogenesis Inhibitors | 1 | 2010 | 2059 | 0.010 |
Why?
|
Pilot Projects | 1 | 2013 | 8742 | 0.010 |
Why?
|
Antigens, CD | 1 | 2010 | 4032 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 3 | 2012 | 36861 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2011 | 3858 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2011 | 4356 | 0.010 |
Why?
|
Heart Rate | 1 | 2010 | 4217 | 0.010 |
Why?
|
Risk | 1 | 2011 | 9621 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2011 | 3442 | 0.010 |
Why?
|
Adult | 2 | 2022 | 223818 | 0.010 |
Why?
|
Disease Progression | 1 | 2014 | 13677 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2013 | 7885 | 0.010 |
Why?
|
Cytokines | 1 | 2011 | 7453 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2011 | 10486 | 0.010 |
Why?
|
Rats | 1 | 2011 | 23847 | 0.010 |
Why?
|
Blood Pressure | 1 | 2010 | 8541 | 0.010 |
Why?
|
Models, Biological | 1 | 2010 | 9499 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2010 | 5707 | 0.010 |
Why?
|
Diet | 1 | 2011 | 8090 | 0.010 |
Why?
|
Mice | 1 | 2010 | 82074 | 0.000 |
Why?
|